Dr. Jürgen Thun

Sektionsleiter für Partikel & Formulierungscharakterisierung in der Abteilung Solid State Sciences. Führung eines Teams von Wissenschaftlerinnen und Wissenschaftlern im Bereich der Thermoanalyse (DSC, TGA, DVS), Partikeleigenschaften (PSD, BET, IGC, Mikroskopie), Spectral Imaging, Mechanische Eigenschaften und Oberflächen-Nanoanalysen (AFM, Nanoindentation).

Board Member of Schweizer Gesellschaft für Thermoanalyse und Kalorimetrie (STK), Swiss Society for Thermal Analysis and Calorimetry

Lecture on: "Polymorphism and Crystallization in Industry"

Leading a team of 10 employees supporting the development of the final and finishing steps of an active pharmaceutical ingredient (e.g., crystallization development, milling, spray drying,...). Planning and allocation of resources for pipeline projects and being responsible for the laboratory infrastructure and safety of the whole section.

Leading a laboratory (GMP) with 3 to 4 employees for thermal analysis of drug substance and drug product, interns and a PostDoc. Part of (multinational) early and late stage project teams, e.g. Alecensa (Chugai, Japan), Cellcept, Idasanutlin, Ipatasertib, Zelboraf.

25% Job-Rotation into the global Manufacturing Science & Technology department dealing with transfer and validation activities at CMOs for late stage and commercial products in a matrix environment

Managing an internal project team of 7 colleagues from different departments on fostering people proficiency and increasing agility and flexibility within the small molecule technical development area

Leading an analytical laboratory in the drug substance late stage development department with 2 employees; analytical project lead.

Leading an analytical laboratory (GMP/GLP) in the early stage development with 1 employee for drug substance and drug product; analytical project lead

Polymorphie-Screening Untersuchungen. Röntgendiffraktometrie, Abteilung Festkörpereigenschaften, Thermoanalyse

Polymorphie-Screening Untersuchungen. Röntgendiffraktometrie

Als Doktorand betreute ich neben der Forschung im Bereich Polymorphie-Screening (Experimentell und mithilfe modernster Computersimulationen) das Lehrstuhlnetzwerk und war Systemadministrator, besonders für meinen kleinen Rechencluster.

Polymorphie-Screening von pharmazeutischen Wirkstoffen Computersimulationen in der Chemie (MC, MD, Quantenmechanik)

Polymorphie-Screening von pharmazeutischen Wirkstoffen Computersimulationen in der Chemie (MC, MD, Quantenmechanik)